Clinical trial
AKL 1 Asthma Study
NCT00407524 · University of Aberdeen, Other · Completed
Key facts
| NCT number | NCT00407524 |
|---|---|
| Title | AKL 1 Asthma Study |
| Official title | AKL1 Asthma Study - Randomised, Double-Blind, Placebo Controlled, Cross Over Study to Determine Safety and Efficacy of Oral AKL1 in Treating Patients With Asthma |
| Lead sponsor | University of Aberdeen, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug |
| Interventions | AKL 1 |
| Enrollment | 40 |
| Start date | Oct 1, 2003 |
| Completion | Mar 1, 2005 |
| First posted | Dec 5, 2006 |
| Last update posted | Dec 5, 2006 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: